Viewing data from:

TOBRAMYCIN AND DEXAMETHASONE

ANDA

DEXAMETHASONE; TOBRAMYCIN | A064134 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TOBRADEX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$5.13

per ml

Lowest NADAC/Unit

$4.28

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
24208029525TOBRAMYCIN-DEXAMETH OPHTH SUSP	$5.13	ML	Generic	—	2026-06-17
24208029510TOBRAMYCIN-DEXAMETH OPHTH SUSP	$4.96	ML	Generic	—	2026-06-17
24208029505TOBRAMYCIN-DEXAMETH OPHTH SUSP	$4.28	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$20.25

Highest Price

$74.91

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
24208-0295-05DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH	$37.13	FSS	Golden State Medical Supply, Inc.	06/14/2028
24208-0295-10DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH	$74.91	FSS	Golden State Medical Supply, Inc.	06/14/2028
24208-0295-25DEXAMETHASONE 0.1%/TOBRAMYCIN 0.3% SUSP,OPH	$20.25	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 27, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.1%;0.3%

0 patents0 exclusivities▴

SUSPENSION/DROPS;OPHTHALMIC | Approved: Oct 27, 1999

No patent or exclusivity listings for this strength.